FDA Adverse Event Injury Summary report: N

COREVALVE

MDR report key: 4012370 · Received August 15, 2014

Report

Report Number
2025587-2014-00577
Event Type
Injury
Date Received
August 15, 2014
Date of Event
July 11, 2014
Report Date
September 5, 2016
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
NPT
PMA / PMN Number
P130021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE HISTORY RECORD WAS REVIEWED AND SHOWED THAT THIS PRODUCT MET ALL MANUFACTURING SPECIFICATIONS FOR PRODUCT RELEASED FOR DISTRIBUTION. NO ISSUES WERE IDENTIFIED THAT WOULD HAVE IMPACTED THIS EVENT. AORTIC REGURGITATION CAN BE CAUSED BY A VARIETY OF FACTORS, INCLUDING VALVE POSITIONING, PATIENT ANATOMY, OR THE PRESENCE OF PRE-EXISTING PATIENT CONDITIONS, AND A CONCLUSIVE CAUSE COULD NOT BE DETERMINED FROM THE INFORMATION AVAILABLE. A SECOND VALVE WAS IMPLANTED WHICH SUCCESSFULLY RESOLVED THE SEVERE REGURGITATION AND REDUCED IT TO MILD. MILD REGURGITATION HAS A MINIMAL IMPACT ON THE PATIENT AND IS GENERALLY DEEMED AN ACCEPTABLE RESIDUAL CONDITION.

Additional Manufacturer Narrative · 1

.

Additional Manufacturer Narrative · 1

THE PRODUCT REMAINS IMPLANTED AND THEREFORE HAS NOT BEEN RETURNED TO MEDTRONIC. A SUPPLEMENTAL REPORT WILL BE FILED WHEN THE INVESTIGATION IS COMPLETED. (B)(4).

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION THAT AORTIC REGURGITATION WAS OBSERVED DUE TO A MODERATE-SEVERE PARAVALVULAR LEAK OBSERVED FOLLOWING THE IMPLANT OF THIS TRANSCATHETER BIOPROSTHETIC VALVE. A SECOND VALVE WAS IMPLANTED VALVE-IN-VALVE, WHICH REDUCED THE LEAK TO MILD. NO ADDITIONAL INTERVENTION WAS PERFORMED. NO SUBSEQUENT ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
489957 COREVALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC HEART VALVES DIVISION MCS-P3-943

Patients

Seq Age Sex Outcome Treatment
1 00085 YR Required Intervention